pág. 323
Advancing towards a male contraceptive: a novel approach from an unexpected direction: a novel approach from an unexpected direction
pág. 326
Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy: a two-pronged strategy in cancer therapy
pág. 328
pág. 331
Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?: a pathway to cancer?
John W. Regan, Hiromichi Fujino
pág. 335
Principles: The need for better experimental design: The need for better experimental design
pág. 341
Ligand-selective receptor conformations revisited: the promise and the problem: the promise and the problem
pág. 346
A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity: inhibitors enhance mutant enzyme activity
pág. 355
Microtubule-interacting drugs for cancer treatment
Paula M. Checchi, James H. Nettles, Jun Zhou, James P. Snyder, Joshi Harish C
pág. 361
Phosphoinositide 3-kinase signalling - which way to target?
Muriel Laffargue, Matthias P. Wymann, Marketa Zvelebil
pág. 366
The glucagon-like peptides: a double-edged therapeutic sword?: a double-edged therapeutic sword?
Nigel H. Greig, TracyAnn Perry
pág. 377
© 2001-2024 Fundación Dialnet · Todos los derechos reservados